arrow_back Back to App

Global Pandemic Preparedness: Accelerating Medical Product Development and Access.

This act aims to establish a global strategy to accelerate the development and availability of medicines and vaccines for future pandemics. Through international cooperation, citizens can expect faster access to essential medical products in public health emergencies, enhancing their safety and protection.
Key points
International Cooperation: The U.S. government will seek support from other countries and organizations to jointly develop medical products against pandemics.
Faster Access to Medicines: The goal is to accelerate research, production, and market entry of medicines and vaccines, including those for superbugs.
Efficient Resource Use: The strategy aims to ensure that funds and efforts are used efficiently, avoiding duplication and focusing on the most critical health threats.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_1305
Sponsor: Rep. Levin, Mike [D-CA-49]
Process start date: 2023-03-01
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

SUPER BUGS Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_1305.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-03-01.

What are the main provisions?

Key points include:

  • International Cooperation: The U.S. government will seek support from other countries and organizations to jointly develop medical products against pandemics.
  • Faster Access to Medicines: The goal is to accelerate research, production, and market entry of medicines and vaccines, including those for superbugs.
  • Efficient Resource Use: The strategy aims to ensure that funds and efforts are used efficiently, avoiding duplication and focusing on the most critical health threats.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Levin, Mike [D-CA-49].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Foreign Affairs.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health